搜索筛选:
搜索耗时1.9478秒,为你在为你在102,285,761篇论文里面共找到 8 篇相符的论文内容
发布年度:
[会议论文] 作者：LiyanJiang,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 Smallcelllungcancer(SCLC)isanaggressivediseasewithpoorsurvival.Afewsequencingstudiesperformedonlimitednumberofsampleshaverevealedpotentialdisease-drivinggenesinSCLC,howe...
[期刊论文] 作者：李燕疆，LiYanjiang,
来源：城市道桥与防洪 年份：2014
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生、测量监控等方面人手,介绍了S226海滨大桥...
IsThereaProgression-freeSurvivalBenefitofFirst-lineCrizotinibversusStandardChemotherapya
[会议论文] 作者：ShaohuaCui,YizhuoZhao,LiliDong,AiqinGu,LiwenXiong,JialinQian,WeiZhang,YanjieNiu,FengPan,LiyanJiang,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 Tocomparetheprogression-freesurvival(PFS)ofChinesepatientswithALK-positive,advancedlungadenocarcinomawhoreceivedfirst-linecrizotinibtherapywiththatofpatientswhoreceivedfirs...
[会议论文] 作者：BaohuiHan;LiwenXiong;JiayuanSun;RongLi;YuqingLou;YanweiZhang;AiqingGu;LiyanJiang;JianxinShi;WentaoFang,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Background: Concurrent chemoradiation therapy or induction chemotherapy plus surgery were considered as standard treatment to non-small-cell lung cancer (NS...
FactorsthatPredictProgression-freeSurvivalinChineseLungAdenocarcinomaPatientsTreatedwith
[会议论文] 作者：ShaohuaCui,LiwenXiong,YuqingLou,HuangpingShi,AiqinGu,YizhuoZhao,TianqingChu,HuiminWang,WeiZhang,LiliDong,LiyanJiang,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 Althoughfirst-generationepidermalgrowthfactorreceptortyrosinekinaseinhibitors(EGFR-TKIs)haveshownefficacyinpatientswithadvancedlungcancers,survivalpredictorswiththesedrugsha...
[会议论文] 作者：ZhouYanjun,周艳军,LiYanjiang,李延江,ZhouYunweng,周耘翁,
来源：中国气象学会2012城市气象论坛 年份：2012
利用2001-2010年1-12月秦皇岛、昌黎、抚宁及青龙观测站资料,筛迷出401个样本个例,应用常规统计学方法及天气学理论,按不同分级统计分析降雨(雪)前6-8小时风向、风速及转为海风时温度变化基数据,计算不同分级相关系数值,得出海上偏东风与降水、温度半定量化估计......
Combination of chemotherapy and gefitinib as first-line treatment of patients with advanced lung ade
[会议论文] 作者：BaohuiHan,BoJin,TianqinChu,YanjieNiu,HuaZhong,YuDong,AiqingGu,HuiminWang,XueyanZhang,PingGu,YuqingLou,LiyanJiang,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 To explore the optimal treatment strategy for patients who harbored a sensitive EGFR mutation.We did a head-to-headstudy to compare chemotherapy and gefitinib in combination with either agent alone...
STAT4 Knockout Protects LPS-induced Lung Injury by Increasing of MDSC and Promoting of Macrophage Di
[会议论文] 作者：CuipingFu[1]LiyanJiang[2]XiaoboXu[1]FenZhu[1]ShuqiZhang[1]XuWu[1]ZilongLiu[1]XiangdongYang[3]ShanqunLi,
来源：第十四次全国中西医结合防治呼吸系统疾病学术研讨会 年份：2016
The disruption of signal transducer and activator of transcription 4 (STAT4) signal can inhibit the inflammation and protect organs from injury during sever...
相关搜索：
